Outcomes of Teleneurology Implementation During the COVID-19 Pandemic
The objective of this study was to assess the implementation of teleneurology, including patient and clinician experiences, during the COVID-19 pandemic.
The objective of this study was to assess the implementation of teleneurology, including patient and clinician experiences, during the COVID-19 pandemic.
Study authors evaluated the effect of telerheumatology and the pandemic on the care of patients in a tertiary outpatient service.
For telemedicine to thrive in a postpandemic era, temporary rules regarding reimbursement and providers’ ability to fully care for the patient in any setting must be made permanent.
Physician’s ponder the future of telehealth post-COVID-19 pandemic.
Telemedicine use increased considerably during the COVID-19 pandemic, with lower use in communities with higher rates of poverty.
Telemedicine delivered over 1 year to patients with severe migraine-related disability was comparable to in-office visits for improving migraine disability, number of headache days, and average headache severity at 12 months.
Compared with rural counties with high broadband availability, rural counties with low broadband availability had 34% fewer telemedicine visits per capita.
Online symptom self-management plus clinician telecare can be effective for individuals with pain, depression, and anxiety.
Long-term follow-up care for the management of migraine with severe disability using telemedicine was found to have comparable efficacy compared to in-office visits.
Broadband penetration rates are considerably lower in the most rural counties, especially where access to primary care physicians and psychiatrists is inadequate.